US2010167352A1PendingUtilityA1

Infectious clones

Assignee: SANCHEZ LUIS ENJUANESPriority: Dec 3, 1999Filed: Sep 30, 2008Published: Jul 1, 2010
Est. expiryDec 3, 2019(expired)· nominal 20-yr term from priority
Inventors:Luis Sanchez
A61P 37/04A61P 43/00A61P 31/12A61P 31/00A61P 29/00A61P 11/00A61P 1/00C07K 14/005C12N 15/70C12N 15/86C12N 2770/20034A61K 39/12A61K 2039/5256C12N 2770/20043A61K 2039/541C12N 2770/20062A61K 39/225C12N 2800/204A61K 2039/53C12N 7/00A61K 2039/525C12N 2800/80C12N 15/11
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to methods of preparing a DNA comprising steps, wherein (a) a DNA comprising a full length copy of the genomic RNA (gRNA) or an RNA virus; or (b) a DNA comprising one or several fragments of a gRNA of an RNA virus, which fragments code for an RNA dependent RNA polymerase and at least one structural or non-structural protein; or (c) a DNA having a homology of at least 60% to the sequences of (a) or (b); is cloned into a bacterial artificial chromosome (BAC). Additionally, DNAs are provided, which comprise sequences derived from the genomic RNA (gRNA) of a coronavirus which sequences have a homology of at least 60% to the natural sequence of the virus and code for an RNA dependent RNA polymerase and at least one structural or no-structural protein, wherein a fragment of said DNA is capable of being transcribed into RNA which RNA can be assembled to a virion. Further, the use of these nucleic acids for preparation of viral RNA or virions as well as pharmaceutical preparations comprising these DNAs, viral RNAs or virions is disclosed.

Claims

exact text as granted — not AI-modified
1 . Method of preparing a DNA comprising steps, wherein
 (a) a DNA comprising a full length copy of the genomic RNA (gRNA) of an RNA virus; or   (b) a DNA comprising one or several fragments of a gRNA of an RNA virus, which fragments code for an RNA dependent RNA polymerase and at least one structural or non-structural protein; or   (c) a DNA having a homology of at least 60% to the sequences of (a) or (b);   
       is cloned into a bacterial artificial chromosome (BAC). 
     
     
         2 - 74 . (canceled)

Join the waitlist — get patent alerts

Track US2010167352A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.